Page last updated: 2024-10-24

verapamil and Intellectual Disability

verapamil has been researched along with Intellectual Disability in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research Excerpts

ExcerptRelevanceReference
"The case of an adolescent with severe mental retardation, blindness, and a complex of behavioral symptoms consistent with mania is reported."1.28Verapamil and valproic acid treatment of prolonged mania. ( Friedman, DL; Kastner, T, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kastner, T1
Friedman, DL1

Other Studies

1 other study available for verapamil and Intellectual Disability

ArticleYear
Verapamil and valproic acid treatment of prolonged mania.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1992, Volume: 31, Issue:2

    Topics: Adolescent; Arousal; Bipolar Disorder; Drug Therapy, Combination; Humans; Intellectual Disability; M

1992